Searched for
HEAD AND NECK CANCER
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- 5 mid-cap stocks from different sectors with an upside potential of 13 to 24% in one year, according to analystsWhen mid-caps were rising, every concern on valuation was treated as unnecessary caution. Investors who advised patience were told they wer...
- Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...
- These large- and mid-cap stocks may give more than 25% return in 1 year, according to analystsFor the last few earnings seasons, the message has been: “Show me growth, I have the money.” Stocks with better-than-expected earnings saw ...
- Volatility as opportunity, depends on framework of mind: 5 mid-caps from different sectors with upside potential of up to 31%The Indian stock market is no longer correcting only because of sentiment. It is now adjusting to the possibility of weaker numbers in the ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Israel's parliament has voted to dissolve itself. What's next?Israel's parliament has voted to dissolve itself. This move could lead to an early national election. Prime Minister Benjamin Netanyahu is ...
- Time to take the first step to become a contrarian? 4 mid-cap stocks from different sectors with upside potential up to 21%As the risk created by the US-Iran war keeps crude oil prices elevated, the list of stocks where investors can deploy fresh money with comf...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%In these times of geopolitical stress, how will things pan out for the Indian market? Will it be a standalone underperformer? Or is it just...
- Alembic Pharma gets USFDA nod for generic cancer, arthritis injectionAlembic Pharmaceuticals has received final approval from the US Food and Drug Administration for its generic methotrexate injection, used t...
- New PMJAY rule bars hundreds of experienced cancer specialists from treating patients under Ayushman Bharat schemeAround 15 lakh cancer cases are detected in India every year, yet several states are excluding hundreds of experienced, fellowship-trained ...
- Genmab to buy Dutch cancer drugmaker Merus for $8 billionDenmark's Genmab has agreed to acquire Dutch biotech Merus NV for $8 billion in cash, adding the head-and-neck cancer drug petosemtamab to ...
- Drinking tea, coffee linked to lower risk of head and neck cancer: StudyDrinking 3-4 cups of coffee daily is linked to a 17% lower risk of head and neck cancers, and one cup of tea daily reduces the risk by 9%, ...
- Cancers in head and neck rising, account for 26% cases in India: StudyA recent study conducted by the Cancer Mukt Bharat Foundation revealed that around 26% of cancer patients in India have tumors in the head ...
- Lupin Partners Enzene to roll out biosimilar Cetuximab hereIn July 2009, the US Food and Drug Administration (USFDA) approved Eli Lilly and Merck's cetuximab (Erbitux) for treatment of metastatic co...
- Lupin launches biosimilar cetuximab in pact with EnzeneCetuximab has received approval from the Drug Controller General of India (DCGI) for its effectiveness in treating head and neck cancer
- Tobacco responsible for rise in head, neck cancer cases: GCRIAn estimated 35% of the 45,000 new cancer cases registered in Gujarat every year are that of the head and neck due to high tobacco consumpt...
Load More
